Pepfar funding to fight HIV/AIDS has saved 26 million lives since 2003: how cutting it will hurt Africa
The US President's Emergency Plan for AIDS Relief has been a cornerstone of global HIV/AIDS prevention, care and treatment ...
Daily2h
Gilead Sciences sets aside USD 200 million to resolve HIV drug investigation
Gilead Sciences has allocated USD 200 million to potentially settle with federal prosecutors to resolve an investigation into ...
Lawyer Monthly5h
Gilead Sciences Sets Aside $200M for HIV Drug Settlement
Gilead Sciences sets aside $200 million for a potential settlement over its HIV drug promotional speaker program amid federal investigation.
bhekisisa.org5h
The Global Fund will roll out the twice-yearly anti-HIV jab — with or without Pepfar
The major backer of the lenacapavir roll-out is assuring nervous researchers that they will keep their part of funding ...
Gilead Sciences sets aside $200 million to resolve HIV drug probe
Gilead Sciences set aside $200 million for a potential settlement with federal prosecutors to resolve an investigation into ...
infectiousdiseaseadvisor.com23h
Twice-Yearly Lenacapavir Gets Priority Review For HIV PrEP
The FDA has accepted under Priority Review the NDA for lenacapavir for the prevention of HIV as pre-exposure prophylaxis.